Naz Rahman

Stock Analyst at Maxim Group

(0.29)
# 4,322
Out of 5,043 analysts
35
Total ratings
20%
Success rate
-45.61%
Average return

Stocks Rated by Naz Rahman

Kazia Therapeutics
Oct 2, 2025
Maintains: Buy
Price Target: $15$20
Current: $7.30
Upside: +173.97%
Aytu BioPharma
Sep 25, 2025
Maintains: Buy
Price Target: $9$7
Current: $2.21
Upside: +216.74%
Galmed Pharmaceuticals
Apr 4, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.38
Upside: -
Nuvectis Pharma
Apr 2, 2025
Initiates: Buy
Price Target: $17
Current: $6.55
Upside: +159.54%
Silexion Therapeutics
Mar 20, 2025
Maintains: Buy
Price Target: $135$75
Current: $3.47
Upside: +2,061.38%
Viking Therapeutics
Feb 7, 2025
Maintains: Buy
Price Target: $120$70
Current: $35.93
Upside: +94.82%
NeuroSense Therapeutics
Dec 16, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.14
Upside: -
Cingulate
Nov 20, 2024
Upgrades: Buy
Price Target: n/a
Current: $3.76
Upside: -
Palisade Bio
Nov 13, 2024
Maintains: Buy
Price Target: $23$8
Current: $1.66
Upside: +381.93%
PainReform
Oct 24, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.32
Upside: -
Initiates: Buy
Price Target: $3
Current: $0.81
Upside: +269.78%
Maintains: Buy
Price Target: $525$140
Current: $13.20
Upside: +960.61%
Downgrades: Hold
Price Target: n/a
Current: $420.17
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $0.31
Upside: -
Initiates: Buy
Price Target: $6
Current: $2.58
Upside: +132.56%